Ubistesin
Ubistesin is a medicine authorised by Swissmedic under authorisation number 49589. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 October 1988 and the authorisation is valid without a time limit. ATC code N01BB58 places the medicine in the group Anesthetics.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ubistesin, Injektionslösung | B | 26 October 1988 |
| 2 | Ubistesin forte, Injektionslösung | B | 26 October 1988 |
| 3 | Ubistesin mite, Injektionslösung | B | 17 November 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 18 | 50 x 1.7 ml | Patronen | N01BB58 | 13.01.2. | B |
| 26 | 50 x 1.7 ml | Patronen | N01BB58 | 13.01.2. | B |
| 1 | 50 x 1.7 ml | Patronen | N01BB58 | 13.01.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ubistesin authorised in Switzerland?
Yes. Ubistesin is authorised by Swissmedic under authorisation number 49589, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ubistesin have?
Ubistesin is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ubistesin?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.